|Bid||25.80 x 1100|
|Ask||25.90 x 1400|
|Day's Range||25.43 - 26.26|
|52 Week Range||11.23 - 29.70|
|PE Ratio (TTM)||N/A|
|YTD Daily Total Return||4.29%|
|Beta (5Y Monthly)||0.00|
|Expense Ratio (net)||0.99%|
The new coronavirus from China has claimed more than 800 lives and there are now more than 37,000 documented cases of the respiratory illness worldwide, making it more deadly than the 2003 SARS epidemic. ...
Benzinga: Taken the first few weeks of 2020 into account, what can you even say about this market right now? Jablonski: So, I think if we take a look at where we are today...December was one of the best months for stock gains in 50 years. For investors just trying to come in and evaluate, the valuations might be a little bit high and the risk of getting in them might be higher, too.
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
If you want to know who really controls Canntab Therapeutics Limited (CNSX:PILL), then you'll have to look at the...
Pharmaceutical ETFs invest in stocks of companies that are involved in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. With Johnson and Johnson continuing ...
Direxion, one of the largest issuers of leveraged exchange traded funds, is planning to change the indexes its leveraged pharmaceuticals and real estate ETFs track. Currently, the Direxion Daily Pharmaceutical ...
NEW YORK , May 31, 2019 /PRNewswire/ -- The Board of Trustees of the Direxion Shares ETF Trust ("Trust") has approved changes to the investment objective, investment strategy and underlying index ...
The simplest way to benefit from a rising market is to buy an index fund. While individual stocks can be big winners...
Big pharmaceutical companies were on the hot seat at Capitol Hill today with CVS Health, Cigna, Prime Therapeutics, Humana, and UnitedHealthcare's OptumRx testifying before the Senate Finance Committee on the rising cost of prescription drugs. Among the topics discussed included rebates paid by drug makers contributing to the high costs and the drug industry's pursuit of profits--all to shift the blame from the pharmaceutical companies to the drug makers. U.S. President Donald Trump has already lambasted the pharmaceutical industry for the rising costs associated with prescription drugs.
The Daily Pharmaceutical & Medical Bull 3X Shares (PILL) gained 1.35 percent on news that General Electric will sell its biopharmaceutical business to conglomerate company Danaher for $21.4 billion. The sale comes as GE CEO Larry Culp is looking to take the company out of its worst slump in its 127-year history.